Riahi A, Shkoor M, Fatunsin O, Lubbe M, Reinke H, Langer P
Tetrahedron Lett. 2020; 50(1):115-117.
PMID: 32287440
PMC: 7111812.
DOI: 10.1016/j.tetlet.2008.10.097.
Khan F, Syeda P, Nartey M, Rahman M, Islam M, Nishimura K
Cytotechnology. 2016; 68(6):2417-2429.
PMID: 26946143
PMC: 5101312.
DOI: 10.1007/s10616-016-9960-7.
Chia E, Kagota S, Wijekoon E, McGuire J
BMC Pharmacol. 2011; 11:10.
PMID: 21955547
PMC: 3192660.
DOI: 10.1186/1471-2210-11-10.
Turner E, Mulvaney E, Reid H, Kinsella B
Mol Biol Cell. 2011; 22(15):2664-79.
PMID: 21653824
PMC: 3145543.
DOI: 10.1091/mbc.E11-04-0374.
Wang M, Ihida-Stansbury K, Kothapalli D, Tamby M, Yu Z, Chen L
Circulation. 2011; 123(6):631-9.
PMID: 21282500
PMC: 3827687.
DOI: 10.1161/CIRCULATIONAHA.110.973685.
Prostanoid receptor antagonists: development strategies and therapeutic applications.
Jones R, Giembycz M, Woodward D
Br J Pharmacol. 2009; 158(1):104-45.
PMID: 19624532
PMC: 2795261.
DOI: 10.1111/j.1476-5381.2009.00317.x.
Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine prehepatic portal hypertension.
Skill N, Theodorakis N, Wang Y, Wu J, Redmond E, Sitzmann J
Am J Physiol Gastrointest Liver Physiol. 2008; 295(5):G953-64.
PMID: 18772366
PMC: 2584826.
DOI: 10.1152/ajpgi.00013.2008.
Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.
Sprague R, Bowles E, Hanson M, Dufaux E, Sridharan M, Adderley S
Microcirculation. 2008; 15(5):461-71.
PMID: 18574748
PMC: 3076303.
DOI: 10.1080/10739680701833804.
Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.
Foudi N, Kotelevets L, Louedec L, Leseche G, Henin D, Chastre E
Br J Pharmacol. 2008; 154(8):1631-9.
PMID: 18516068
PMC: 2518470.
DOI: 10.1038/bjp.2008.214.
Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets.
Khasawneh F, Huang J, Mir F, Srinivasan S, Tiruppathi C, Le Breton G
Biochem Pharmacol. 2008; 75(12):2301-15.
PMID: 18455148
PMC: 3710659.
DOI: 10.1016/j.bcp.2008.03.014.
IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
Falcetti E, Flavell D, Staels B, Tinker A, Haworth S, Clapp L
Biochem Biophys Res Commun. 2007; 360(4):821-7.
PMID: 17624303
PMC: 1997304.
DOI: 10.1016/j.bbrc.2007.06.135.
Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function.
Idzko M, Hammad H, van Nimwegen M, Kool M, Vos N, Hoogsteden H
J Clin Invest. 2007; 117(2):464-72.
PMID: 17273558
PMC: 1783814.
DOI: 10.1172/JCI28949.
Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations.
Jones R, Wise H, Clark R, Whiting R, Bley K
Br J Pharmacol. 2006; 149(1):110-20.
PMID: 16880763
PMC: 1629403.
DOI: 10.1038/sj.bjp.0706841.
RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.
Bley K, Bhattacharya A, Daniels D, Gever J, Jahangir A, Oyang C
Br J Pharmacol. 2005; 147(3):335-45.
PMID: 16331286
PMC: 1751302.
DOI: 10.1038/sj.bjp.0706554.